84 related articles for article (PubMed ID: 21810459)
1. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
Chang JS; Wang KC; Shieh DE; Chiang LC
J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
[TBL] [Abstract][Full Text] [Related]
2. Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
Chang JS; Wang KC; Yeh CF; Shieh DE; Chiang LC
J Ethnopharmacol; 2013 Jan; 145(1):146-51. PubMed ID: 23123794
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazole analogs inhibit respiratory syncytial virus G protein function.
Evans CW; Atkins C; Pathak A; Gilbert BE; Noah JW
Antiviral Res; 2015 Sep; 121():31-8. PubMed ID: 26116756
[TBL] [Abstract][Full Text] [Related]
4. The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins.
Touzelet O; Broadbent L; Armstrong SD; Aljabr W; Cloutman-Green E; Power UF; Hiscox JA
Mol Cell Proteomics; 2020 May; 19(5):793-807. PubMed ID: 32075873
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System.
Haid S; Grethe C; Bankwitz D; Grunwald T; Pietschmann T
J Virol; 2015 Dec; 90(6):3065-73. PubMed ID: 26719246
[TBL] [Abstract][Full Text] [Related]
7. DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding.
Li CM; Zheng LL; Yang XX; Wan XY; Wu WB; Zhen SJ; Li YF; Luo LF; Huang CZ
Biomaterials; 2016 Jan; 77():216-26. PubMed ID: 26606447
[TBL] [Abstract][Full Text] [Related]
8. Transmission of Human Respiratory Syncytial Virus in the Immunocompromised Ferret Model.
de Waal L; Smits SL; Veldhuis Kroeze EJB; van Amerongen G; Pohl MO; Osterhaus ADME; Stittelaar KJ
Viruses; 2018 Jan; 10(1):. PubMed ID: 29301313
[TBL] [Abstract][Full Text] [Related]
9. A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial Virus.
Le Rouzic A; Fix J; Vinck R; Kappler-Gratias S; Volmer R; Gallardo F; Eléouët JF; Keck M; Cintrat JC; Barbier J; Gillet D; Galloux M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203585
[TBL] [Abstract][Full Text] [Related]
10. Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update.
Vázquez Y; González L; Noguera L; González PA; Riedel CA; Bertrand P; Bueno SM
Front Immunol; 2019; 10():1154. PubMed ID: 31214165
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.
Magro M; Andreu D; Gómez-Puertas P; Melero JA; Palomo C
J Virol; 2010 Aug; 84(16):7970-82. PubMed ID: 20534864
[TBL] [Abstract][Full Text] [Related]
12. A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform.
Park M; Matsuura H; Lamb RA; Barron AE; Jardetzky TS
Anal Biochem; 2011 Feb; 409(2):195-201. PubMed ID: 20971054
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of three triterpene series and their activity against respiratory syncytial virus.
Santos da Silva GN; Monti Atik D; Antunes Fernandes JL; de Freitas do Nascimento D; Fazolo T; Duarte de Souza AP; Baggio Gnoatto SC
Arch Pharm (Weinheim); 2018 Jul; ():e1800108. PubMed ID: 29999539
[TBL] [Abstract][Full Text] [Related]
14. Pathogenicity and virulence of human respiratory syncytial virus: Multifunctional nonstructural proteins NS1 and NS2.
Merritt TN; Pei J; Leung DW
Virulence; 2023 Nov; ():2283897. PubMed ID: 37964591
[TBL] [Abstract][Full Text] [Related]
15. Two synthetic steroid analogs reduce human respiratory syncytial virus replication and the immune response to infection both
Bueno CA; Salinas FM; Vazquez L; Alché LE; Michelini FM
Heliyon; 2023 Oct; 9(10):e20148. PubMed ID: 37822633
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus.
Dudek I; Czerkies M; Kwiatek A
Virology; 2024 Jun; 597():110127. PubMed ID: 38850893
[TBL] [Abstract][Full Text] [Related]
17. [Current Status of Surveillance Systems for Human Respiratory Syncytial Virus].
Xia BC; Cong BB; Wang HL; Ma SH; Song JH; Wang N; Zhang Y; Li Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58():1-18. PubMed ID: 38403284
[TBL] [Abstract][Full Text] [Related]
18. Some new insights into the biological activities of carboxymethylated polysaccharides from Lasiodiplodia theobromae.
Pires MC; de Gois Andriolo N; Lopes BRP; Ruiz ALTG; do Nascimento VMG; Toledo KA; Santos CD
BMC Complement Med Ther; 2023 Oct; 23(1):356. PubMed ID: 37805488
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Effect of Hyunggaeyungyo-Tang on A549 Cells Infected with Human Coronavirus.
Won SY; Seol IC; Yoo HR; Kim YS
Evid Based Complement Alternat Med; 2021; 2021():4494389. PubMed ID: 34659433
[TBL] [Abstract][Full Text] [Related]
20. Prior respiratory syncytial viral infection contributes to severe COVID-19 illness: A nationwide cohort study.
Lee HJ; Kim MJ; Kim JS; Lee YC; Jeong JS
Allergy; 2024 Apr; ():. PubMed ID: 38577792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
